Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.

BACKGROUND:In hospitals around the world, there has been no consensus regarding which clinical activities a pharmacist should focus on until recently. In 2011, a Canadian clinical pharmacy key performance indicator (cpKPI) collaborative was formed. The goal of the collaborative was to advance pharma...

Full description

Bibliographic Details
Main Authors: Laura V Minard, Heidi Deal, Megan E Harrison, Kent Toombs, Heather Neville, Andrea Meade
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4820256?pdf=render
id doaj-b7f9fbdbcbd34ada8dfcd8586fb215fd
record_format Article
spelling doaj-b7f9fbdbcbd34ada8dfcd8586fb215fd2020-11-25T01:31:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01114e015290310.1371/journal.pone.0152903Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.Laura V MinardHeidi DealMegan E HarrisonKent ToombsHeather NevilleAndrea MeadeBACKGROUND:In hospitals around the world, there has been no consensus regarding which clinical activities a pharmacist should focus on until recently. In 2011, a Canadian clinical pharmacy key performance indicator (cpKPI) collaborative was formed. The goal of the collaborative was to advance pharmacy practice in order to improve patient outcomes and enhance the quality of care provided to patients by hospital pharmacists. Following a literature review, which indicated that pharmacists can improve patient outcomes by carrying out specific activities, and an evidence-informed consensus process, a final set of eight cpKPIs were established. Canadian hospitals leading the cpKPI initiative are currently in the early stages of implementing these indicators. OBJECTIVE:To explore pharmacists' perceptions of the barriers and facilitators to the implementation of cpKPIs. METHODS:Clinical pharmacists employed by the Nova Scotia Health Authority were invited to participate in focus groups. Focus group discussions were audio-recorded and transcribed, and data was analyzed using thematic analysis. FINDINGS:Three focus groups, including 26 pharmacists, were conducted in February 2015. Three major themes were identified. Resisting the change was comprised of documentation challenges, increased workload, practice environment constraints, and competing priorities. Embracing cpKPIs was composed of seeing the benefit, demonstrating value, and existing supports. Navigating the unknown was made up of quality versus quantity battle, and insights into the future. CONCLUSIONS:Although pharmacists were challenged by documentation and other changes associated with the implementation of cpKPIs, they demonstrated significant support for cpKPIs and were able to see benefits of the implementation. Pharmacists came up with suggestions for overcoming resistance associated with the implementation of cpKPIs and provided insights into the future of pharmacy practice. The identification of barriers and facilitators to cpKPI implementation will be used to inform the implementation process on a local and national level.http://europepmc.org/articles/PMC4820256?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Laura V Minard
Heidi Deal
Megan E Harrison
Kent Toombs
Heather Neville
Andrea Meade
spellingShingle Laura V Minard
Heidi Deal
Megan E Harrison
Kent Toombs
Heather Neville
Andrea Meade
Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
PLoS ONE
author_facet Laura V Minard
Heidi Deal
Megan E Harrison
Kent Toombs
Heather Neville
Andrea Meade
author_sort Laura V Minard
title Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
title_short Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
title_full Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
title_fullStr Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
title_full_unstemmed Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.
title_sort pharmacists' perceptions of the barriers and facilitators to the implementation of clinical pharmacy key performance indicators.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description BACKGROUND:In hospitals around the world, there has been no consensus regarding which clinical activities a pharmacist should focus on until recently. In 2011, a Canadian clinical pharmacy key performance indicator (cpKPI) collaborative was formed. The goal of the collaborative was to advance pharmacy practice in order to improve patient outcomes and enhance the quality of care provided to patients by hospital pharmacists. Following a literature review, which indicated that pharmacists can improve patient outcomes by carrying out specific activities, and an evidence-informed consensus process, a final set of eight cpKPIs were established. Canadian hospitals leading the cpKPI initiative are currently in the early stages of implementing these indicators. OBJECTIVE:To explore pharmacists' perceptions of the barriers and facilitators to the implementation of cpKPIs. METHODS:Clinical pharmacists employed by the Nova Scotia Health Authority were invited to participate in focus groups. Focus group discussions were audio-recorded and transcribed, and data was analyzed using thematic analysis. FINDINGS:Three focus groups, including 26 pharmacists, were conducted in February 2015. Three major themes were identified. Resisting the change was comprised of documentation challenges, increased workload, practice environment constraints, and competing priorities. Embracing cpKPIs was composed of seeing the benefit, demonstrating value, and existing supports. Navigating the unknown was made up of quality versus quantity battle, and insights into the future. CONCLUSIONS:Although pharmacists were challenged by documentation and other changes associated with the implementation of cpKPIs, they demonstrated significant support for cpKPIs and were able to see benefits of the implementation. Pharmacists came up with suggestions for overcoming resistance associated with the implementation of cpKPIs and provided insights into the future of pharmacy practice. The identification of barriers and facilitators to cpKPI implementation will be used to inform the implementation process on a local and national level.
url http://europepmc.org/articles/PMC4820256?pdf=render
work_keys_str_mv AT lauravminard pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
AT heidideal pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
AT meganeharrison pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
AT kenttoombs pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
AT heatherneville pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
AT andreameade pharmacistsperceptionsofthebarriersandfacilitatorstotheimplementationofclinicalpharmacykeyperformanceindicators
_version_ 1725084401558093824